This emotional television commercial for the immunotherapy drug Opdivo showcases a father-son relationship affected by advanced squamous, non-small cell lung cancer. Titled 'Longer Life,' the emotive ad spot showcases the exciting potential of the drug, which is intended for patients previously treated with platinum-based chemotherapy that did not succeed.
Shot in the architectural wonder of downtown Chicago, the Opdivo commercial highlights the risks involved with taking the drug as well as the results of a recent clinical study, which suggested that Opdivo reduced the risk of dying in studied patients by 41% compared to chemotherapy.
Opdivo, an intravenous drug manufactured by Bristol-Myers Squibb, is currently the only immunotherapy drug approved by the FDA for the treatment of advanced squamous, non-small cell lung cancer.
Immunotherapy Drug Ads
More Stats +/-
Young Love Healthcare Ads
Senior Influenza PSAs
Same-Sex Coverage Campaigns
Active MS Treatment Ads
Touching Healthcare Service Ads
Free 2019 Report & eBook
Get the top 100 trends happening right NOW -- plus a FREE copy of our award-winning book.
Our Research Methodology
This article is one of 350,000 experiments. We use crowd filtering, big data and AI to identify insights.
This Ad Spot for Opdivo Highlights a Recently Approved Treatment
- By: Rebecca ByersDec 2, 2015